Edwards Lifesciences Corp. (EW) reported earnings for third quarter that Decreased from the same period last year but beat the Street estimates.
The company's earnings came in at $292.3 million, or $0.50 per share. This compares with $362.1 million, or $0.61 per share, last year.
Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $389.9 million or $0.67 per share for the period.
Analysts on average had expected the company to earn $0.59 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 14.7% to $1.553 billion from $1.354 billion last year.
Edwards Lifesciences Corp. earnings at a glance (GAAP) :
-Earnings: $292.3 Mln. vs. $362.1 Mln. last year.-EPS: $0.50 vs. $0.61 last year.-Revenue: $1.553 Bln vs. $1.354 Bln last year.
-Guidance:Next quarter EPS guidance: $0.58 - $0.64Next quarter revenue guidance: $1.51 - $1.59 BlnFull year EPS guidance: $2.56 - $2.62
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.